The onset location of multiple sclerosis predicts the location of subsequent relapses
Ellen M. Mowry(Johns Hopkins University), E. Waubant(University of California, San Francisco), Irina Malikova(Délégation Provence et Corse), Jean Pelletier(Hôpital de la Timone), Suha Deen(Nottingham University Hospitals NHS Trust), Peter Bacchetti(University of California, San Francisco)
Cited by 51
Related Papers
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Liver Transplantation for Hepatocellular Carcinoma: Expansion of the Tumor Size Limits Does Not Adversely Impact Survival
|Hepatology|2001|2.3k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k
Age Affects Outcomes in Chronic Kidney Disease
|Journal of the American Society of Nephrology|2007|749
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624